Adam Diehl

2PUBLICATIONS
15CO-AUTHORS
ChemotherapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Aug 10, 2026
Ex vivo tumor derived organoid pharmacotyping identifies personalized therapeutic options for biliary tract cancer patients.

|Sep 20, 2022
KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas.

Adam C Diehl, Lindsay M Hannan, David B Zhen

Pageof 1

Frequent Collaborators

1 joint publications

Veena Shankaran

1 joint publications

Annie Blair Richardson

1 joint publications

Payel Chatterjee

1 joint publications

Rachele Rosati

1 joint publications

Alex Rajewski

1 joint publications

Robert L Diaz

1 joint publications

Lauren R Appleyard

1 joint publications

Shalini Pereira

1 joint publications

Brady Bernard

1 joint publications

Milind M Javle

Frequent Collaborators

1 joint publications

Veena Shankaran

1 joint publications

Annie Blair Richardson

1 joint publications

Payel Chatterjee

1 joint publications

Rachele Rosati

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

894
See more related videos

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

894
See more related videos